Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID–19): a review. JAMA. 2020;324(8):782–93.
Article
CAS
PubMed
Google Scholar
Vabret N. Preclinical data from SARS-CoV–2 mRNA vaccine. Nat Rev Immunol. 2020;20(8):461.
Article
CAS
PubMed
Google Scholar
Ahammad I, Lira SS. Designing a novel mRNA vaccine against SARS-CoV–2: An immunoinformatics approach. Int J Biol Macromol. 2020;162:820–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rahman IU, Ali N, Ijaz F, Afzal A, Abd Allah EF. COVID–19 - Important considerations for developing and using a vaccine. Hum Vaccin Immunother. 2020:1–2.
Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev Sci Tech. 2007;26(1):29–48.
Article
CAS
PubMed
Google Scholar
Plotkin SA. Vaccines: past, present and future. Nat Med. 2005;11(4 Suppl):S5-11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol. 2009;16(12):1709–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269.
Article
PubMed
PubMed Central
Google Scholar
Biggs PM. Gordon memorial lecture. Vaccines and vaccination - past, present and future. Br Poult Sci. 1990;31(1):3–22.
Article
CAS
PubMed
Google Scholar
Davenport FM. Inactivated influenza virus vaccines. Past, present, and future. Am Rev Respir Dis. 1961;832(2)Pt):146–56.
Google Scholar
Plotkin SA, Rees J. Vaccines: facing complex problems with the promise of immunology. Expert Rev Vaccines. 2014;13(8):939–41.
Article
CAS
PubMed
Google Scholar
Blakney AK, Ip S, Geall AJ. An update on self-amplifying mRNA vaccine development. Vaccines (Basel). 2021;9(2):97.
Article
Google Scholar
Plotkin SA. Updates on immunologic correlates of vaccine-induced protection. Vaccine. 2020;38(9):2250–7.
Article
CAS
PubMed
Google Scholar
Pascolo S. Synthetic messenger RNA-based vaccines: from scorn to hype. Viruses. 2021;13(2):270.
Article
CAS
PubMed
PubMed Central
Google Scholar
Piret J, Boivin G. Pandemics throughout history. Front Microbiol. 2020;11:631736.
Article
PubMed
Google Scholar
Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X: Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery. Adv Healthc Mater 2021:e2001812.
Xu S, Yang K, Li R, Zhang L. mRNA vaccine era-mechanisms, drug platform and clinical prospection. Int J Mol Sci. 2020;21(18):6582.
Article
CAS
PubMed Central
Google Scholar
Van Lint S, Heirman C, Thielemans K, Breckpot K. mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. Hum Vaccin Immunother. 2013;9(2):265–74.
Article
PubMed
PubMed Central
CAS
Google Scholar
Schlake T, Thess A, Fotin-Mleczek M, Kallen KJ. Developing mRNA-vaccine technologies. RNA Biol. 2012;9(11):1319–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gergen J, Petsch B: mRNA-based vaccines and mode of action. Curr Top Microbiol Immunol 2021 [Feb 17, online ahead of print].
Lu J, Lu G, Tan S, Xia J, Xiong H, Yu X, Qi Q, Yu X, Li L, Yu H, et al. A COVID–19 mRNA vaccine encoding SARS-CoV–2 virus-like particles induces a strong antiviral-like immune response in mice. Cell Res. 2020;30(10):936–9.
Article
CAS
PubMed
Google Scholar
Meyer M, Huang E, Yuzhakov O, Ramanathan P, Ciaramella G, Bukreyev A. Modified mRNA-based vaccines elicit robust immune responses and protect guinea pigs from Ebola virus disease. J Infect Dis. 2018;217(3):451–5.
Article
CAS
PubMed
Google Scholar
Rauch S, Jasny E, Schmidt KE, Petsch B: Newvaccinetechnologiestocombatoutbreaksituations. FrontImmunol 2018,9:1963.
Linares-Fernandez S, Lacroix C, Exposito JY, Verrier B. Tailoring mRNA vaccine to balance innate/adaptive immune response. Trends Mol Med. 2020;26(3):311–23.
Article
CAS
PubMed
Google Scholar
Sandbrink JB, Shattock RJ. RNA vaccines: a suitable platform for tackling emerging pandemics? Front Immunol. 2020;11:608460.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang NN, Li XF, Deng YQ, Zhao H, Huang YJ, Yang G, Huang WJ, Gao P, Zhou C, Zhang RR, et al. A thermostable mRNA vaccine against COVID–19. Cell. 2020;182(5):1271-1283 e1216.
Article
CAS
PubMed
PubMed Central
Google Scholar
Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8(2):129–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, et al. Safety and Efficacy of the BNT162b2 mRNA Covid–19 Vaccine. N Engl J Med. 2020;383(27):2603–15.
Article
CAS
PubMed
Google Scholar
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and Safety of the mRNA–1273 SARS-CoV–2 Vaccine. N Engl J Med. 2021;384(5):403–16.
Article
CAS
PubMed
Google Scholar
Castells MC, Phillips EJ. Maintaining safety with SARS-CoV–2 vaccines. N Engl J Med. 2021;384(7):643–9.
Article
CAS
PubMed
Google Scholar
Caminati M, Guarnieri G, Senna G. Who is really at risk for anaphylaxis due to COVID–19 vaccine? Vaccines (Basel). 2021;9(1):38.
Article
Google Scholar
Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Ebisawa M, El-Gamal Y, Fineman S, Geller M, Gonzalez-Estrada A, Greenberger PA, et al. COVID–19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organ J. 2021;14(2):100517.
Article
PubMed
PubMed Central
Google Scholar
Cirillo N. Reported orofacial adverse effects of COVID–19 vaccines: The knowns and the unknowns. J Oral Pathol Med. 2021 [Feb 1, online ahead of print].
Repajic M, Lai XL, Xu P, Liu A. Bell’s Palsy after second dose of Pfizer COVID–19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. 2021;13:100217.
Article
PubMed
PubMed Central
Google Scholar
Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immunoaging on SARS- CoV–2 vaccine development. Geroscience. 2021. Online ahead of print.
Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. Safety and immunogenicity of SARS-CoV–2 mRNA–1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427–38.
Article
CAS
PubMed
Google Scholar
Delahoy MJ, Whitaker M, O’Halloran A, Chai SJ, Kirley PD, Alden N, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID–19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, Aveni K, Yazdy MM, Harvey E, Longcore ND, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV–2 infection in pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vermillion MS, Klein SL. Pregnancy and infection: using disease pathogenesis to inform vaccine strategy. NPJ Vaccines. 2018;3:6.
Article
PubMed
PubMed Central
Google Scholar
Klein SL, Creisher PS, Burd I. COVID–19 vaccine testing in pregnant females is necessary. J Clin Invest. 2021;131(5):e147553.
Article
CAS
PubMed Central
Google Scholar
Walsh EE, Frenck RW, Falsey AR Jr., Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R. Safety and immunogenicity of bwo RNA-based Covid–19 vaccine candidates. N Engl J Med. 2020;383(25):2439–50.
Article
CAS
PubMed
Google Scholar
Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601–10.
Article
CAS
PubMed
Google Scholar
Helmo FR, Alves EAR, Moreira RAA, Severino VO, Rocha LP, Monteiro M, Reis MAD, Etchebehere RM, Machado JR, Correa RRM. Intrauterine infection, immune system and premature birth. J Matern Fetal Neonatal Med. 2018;31(9):1227–33.
Article
PubMed
Google Scholar
Adhikari EH, Moreno W, Zofkie AC, MacDonald L, McIntire DD, Collins RRJ, Spong CY. Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection. JAMA Netw Open. 2020;3(11):e2029256.
Article
PubMed
PubMed Central
Google Scholar
Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, et al. COVID–19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594–9.
Article
CAS
PubMed
Google Scholar
Sonani B, Aslam F, Goyal A, Patel J, Bansal P. COVID–19 vaccination in immunocompromised patients. Clin Rheumatol. 2021;40(2):797–8.
Article
PubMed
Google Scholar
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, et al. An mRNA vaccine against SARS-CoV–2 - preliminary report. N Engl J Med. 2020;383(20):1920–31.
Article
CAS
PubMed
Google Scholar
Cordero DA: Rebuilding public trust: a clarified response to COVID–19 vaccine hesitancy predicament. J Public Health (Oxf) 2021. [Feb 5, online ahead of print].
Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID–19. Eur J Epidemiol. 2020;35(8):775–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lurie N, Saville M, Hatchett R, Halton J. Developing Covid–19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73.
Article
CAS
PubMed
Google Scholar
Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID–19 vaccination. JAMA Netw Open. 2020;3(10):e2025594.
Article
PubMed
PubMed Central
Google Scholar
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID–19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
Article
PubMed
PubMed Central
Google Scholar
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID–19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020;38(42):6500–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, Preiss S. Vaccine strategies: optimising outcomes. Vaccine. 2016;34(52):6691–9.
Article
PubMed
Google Scholar
Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccinationa coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764.
Article
PubMed
PubMed Central
Google Scholar
Jacobson RM, Agunwamba AA, St Sauver JL, Finney Rutten LJ. The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Rev Vaccines. 2016;15(2):257–69.
Article
CAS
PubMed
Google Scholar
Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID–19 vaccination program. JAMA. 2020;323(24):2458–9.
Article
PubMed
CAS
Google Scholar
Chou WS, Budenz A. Considering emotion in COVID–19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020;35(14):1718–22.
Article
PubMed
Google Scholar
Kaiser Family Foundation: COVID–19 Vaccine Monitor: December2020.https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/. Accessed 5 Apr 2021.